Group 1 - The core viewpoint is that in H1 2025, the cosmetics retail sales growth has reversed its decline, achieving a growth rate of 2.9% due to consumption-boosting policies and improved income expectations [1][2] - The demand for cosmetics is expected to remain strong in H2 2025, with the off-peak season in July and August showing increased growth, indicating positive demand expectations [1][2] - The competitive landscape is improving, with domestic brands making significant progress, and leading domestic brands are now sharing market share equally with international brands [2] Group 2 - In the cosmetics sector, the revenue growth rate for key covered companies in H1 2025 is around 8%, with net profit growth slightly lower than revenue growth [2] - Specific companies in the cosmetics sector include: - Shiseido: H1 2025 revenue of 4.11 billion yuan, up 17.3%, net profit of 520 million yuan, up 30.6% [2] - Proya: H1 2025 revenue of 5.36 billion yuan, up 7.2%, net profit of 800 million yuan, up 13.8% [2] - Water Sheep: H1 2025 revenue of 2.5 billion yuan, up 9.0%, net profit of 123 million yuan, up 16.5% [2] - Marubi: H1 2025 revenue of 1.77 billion yuan, up 30.8%, net profit of 190 million yuan, up 5.2% [2] Group 3 - The second category of companies is capitalizing on consumer trends, with notable performances including: - Mao Geping: H1 2025 revenue of 2.59 billion yuan, up 31.3%, net profit of 670 million yuan, up 36.1% [3] - Juzi Biotechnology: H1 2025 revenue of 3.11 billion yuan, up 22.5%, net profit of 1.18 billion yuan, up 20.2% [3] - The third category includes companies showing marginal improvements or initial signs of strategic transformation, such as Shanghai Jahwa, Huaxi Biological, and Betaini [3] Group 4 - In the personal care sector, two companies reported revenue and net profit growth, indicating a strong market potential: - RuYuchen: H1 2025 revenue of 1.32 billion yuan, up 67.6%, net profit of 70 million yuan, up 85.6% [3] - Runben: H1 2025 revenue of 900 million yuan, up 20.3%, net profit of 190 million yuan, up 4.2% [3] Group 5 - In the medical beauty sector, the performance is mixed, with some companies experiencing declines: - Aimeike: H1 2025 revenue of 1.3 billion yuan, down 21.6%, net profit of 790 million yuan, down 29.6% [4] - Langzi: H1 2025 revenue of 2.79 billion yuan, down 4.3%, net profit of 270 million yuan, up 64.1% [4] - Overall, the medical beauty sector reported a revenue of 1.333 billion yuan, down 6.1%, with a gross margin of 54.54% [4]

Core Insights - Runben Co., Ltd. experienced a stock price increase of 2.84% on September 23, with a trading volume of 199 million yuan [1] - The company reported a financing net purchase of 19.41 million yuan on the same day, indicating strong investor interest [1][2] - As of June 30, 2025, Runben's revenue reached 895 million yuan, reflecting a year-on-year growth of 20.31% [2] Financing and Margin Trading - On September 23, Runben's financing buy amounted to 40.59 million yuan, with a total financing balance of 333 million yuan, representing 10.97% of its market capitalization [1] - The financing balance is above the 90th percentile of the past year, indicating a high level of leverage [1] - The company also reported a margin trading situation with a short selling amount of 2.94 million yuan and a remaining short selling balance of 249,500 yuan [1] Shareholder and Institutional Holdings - As of June 30, 2025, the number of shareholders increased by 60.52% to 16,600, while the average number of circulating shares per person decreased by 37.70% to 6,211 shares [2] - Runben has distributed a total of 316 million yuan in dividends since its A-share listing [3] - New institutional shareholders include Hong Kong Central Clearing Limited and Guotai Consumer Preferred Stock, among others, indicating growing institutional interest [3]

Investment Rating - The report maintains a "Positive" outlook on the beauty and personal care industry, highlighting the resilience of domestic brands and the impact of new consumption trends [2]. Core Insights - The beauty and personal care sector experienced a robust recovery in H1 2025, with a retail sales growth of 2.9%, reversing the previous decline due to favorable consumption policies and improved income expectations [5][6]. - Domestic brands are gaining market share, with top local brands now competing closely with international counterparts, indicating a significant shift in consumer preferences [10][11]. - The report categorizes companies into three groups based on performance: those with strong brand matrices benefiting from multi-brand strategies, those capitalizing on consumer trends like domestic brands and collagen products, and those showing signs of strategic improvement [20][23]. Summary by Sections Industry Overview - The beauty market is projected to grow steadily, with a forecasted retail sales decline of 1.1% in 2024, followed by a recovery in H2 2025 [5][6]. - The domestic market share is expected to increase, with local brands achieving significant breakthroughs in both skincare and makeup segments [10][11]. Company Performance - **Cosmetics Sector**: - Major companies like Up Beauty and Proya reported revenue growth of 17.3% and 7.2% respectively in H1 2025, with net profits increasing by 30.6% and 13.8% [20][21]. - Other notable performers include Marubi and Water Sheep, with revenue growth of 30.8% and 9.0% respectively [21][22]. - **Personal Care Sector**: - Companies like Ruibin and Zhenjia showed remarkable growth, with Ruibin's revenue increasing by 67.6% and Zhenjia's by 157.11% in H1 2025 [5][20]. - **Medical Aesthetics Sector**: - Companies like Aimeike and Langzi reported mixed results, with Aimeike's revenue declining by 21.6% while Langzi's net profit surged by 64.1% [20][24]. Investment Recommendations - The report recommends investing in companies with strong brand matrices and low PE multiples, such as Up Beauty and Proya, as well as those benefiting from the Douyin traffic boost like Marubi and Water Sheep [20][24]. - It also suggests focusing on high-value segments and innovative products from brands like Ruibin and Furuida, and highlights opportunities in the maternal and infant sector with companies like Shengbeila and Haiziwang [20][24].

Core Insights - The personal care products sector experienced a decline of 1.62% on September 22, with Zhongshun Jierou leading the drop [1] - The Shanghai Composite Index closed at 3828.58, up 0.22%, while the Shenzhen Component Index closed at 13157.97, up 0.67% [1] Stock Performance Summary - The top gainers in the personal care sector included: - Beijiajie (603059) with a closing price of 35.18, up 2.90% [1] - Jieya Co. (301108) with a closing price of 31.86, up 2.77% [1] - Runben Co. (603193) with a closing price of 28.54, up 1.39% [1] - The top losers included: - Zhongshun Jierou (002511) with a closing price of 8.24, down 3.29% [2] - Yanjian Co. (300658) with a closing price of 8.39, down 2.44% [2] - Wanjian Medical (300888) with a closing price of 38.51, down 1.89% [2] Capital Flow Analysis - The personal care products sector saw a net outflow of 44.93 million yuan from institutional investors, while retail investors contributed a net inflow of 38.55 million yuan [2] - The detailed capital flow for selected stocks showed: - Beijiajie had a net outflow of 6.49 million yuan from institutional investors [3] - Runben Co. had a net inflow of 6.24 million yuan from institutional investors [3] - Zhongshun Jierou experienced a net outflow of 5.02 million yuan from institutional investors [3]

2025 年 09 月 22 日 开源晨会 0922 ——晨会纪要 | 沪深300 | 及创业板指数近1年走势 | 吴梦迪（分析师） | wumengdi@kysec.cn | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 沪深300 | 创业板指 | 证书编号：S0790521070001 | 120% | | | | | | | | 观点精粹 | 90% | | | | | | | | | | 总量视角 | 60% | 【策略】坚持科技，高低切的时机尚未到来——投资策略周报-20250920 | 30% | | | | | | | | 【固定收益】8 | 月财政收支均放缓，政策加码预期升温——2025 | 年 | 月财政数据 | 8 | 0% | 2024-09 | 2025-01 | 2025-05 | 点评-20250919 | | 数据来源：聚源 | 【金融工程】商品择时及其在资产配置中的应用——大类资产配置研究系列（13） | | | | | | | | | | -20250919 | 昨日涨 ...

Investment Rating - The report initiates coverage with a "Buy" rating for the company Water Sheep Co., Ltd. [14] Core Insights - The cosmetics and medical beauty sector has underperformed the market, with the Shenwan Beauty Care Index declining by 2.5% from September 12 to September 19, 2025 [3][4] - The upcoming Double 11 shopping festival is expected to drive significant growth for domestic brands, with recommendations to focus on strong alpha stocks [9][10] - Water Sheep Co., Ltd. is highlighted for its dual business model of proprietary and CP brands, with stable revenue projections of 4-5 billion yuan from 2021 to 2024 and an expected gross margin of 63.01% in 2024 [10][11] Summary by Sections Industry Performance - The cosmetics and medical beauty sector has shown weaker performance compared to the market, with specific indices declining [3][4] - The Shenwan Cosmetics Index fell by 2.6%, while the Shenwan Personal Care Index decreased by 0.6% [4][6] Upcoming Events - The Double 11 shopping festival preparations are in full swing, with domestic brands like Up Beauty and Proya launching new products to capture market share [9] - Key influencers are negotiating promotional strategies to enhance sales during the festival [9] Company Focus: Water Sheep Co., Ltd. - Water Sheep Co., Ltd. is positioned as a leading tech-driven beauty company with a stable revenue forecast and improving profit margins [10][11] - The company has a well-structured brand matrix and is expanding its high-end product lines, with significant growth in its proprietary brands [11][12] - Expected net profits for Water Sheep Co., Ltd. are projected to be 258 million, 331 million, and 398 million yuan for 2025, 2026, and 2027, respectively, indicating substantial growth [14] Market Trends - The Chinese beauty market is witnessing a shift towards domestic brands, with significant market share gains for local players [27] - The overall retail sales of cosmetics showed a growth of 5.1% in August 2025, indicating a recovery in consumer spending [18][21] International Recognition - Chinese beauty brands performed notably at the IFSCC conference, showcasing their advancements in cosmetic science and securing significant awards [22][24]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Views - The retail industry is experiencing a shift towards emotional consumption, with brands that possess differentiated product capabilities and deep consumer insights gaining traction [31] - The report highlights the strong performance of the jewelry sector, particularly in high-end and fashion segments, driven by consumer preferences and innovative marketing strategies [31][39] Summary by Sections Retail Market Overview - The retail index closed at 2384.72 points, down 0.51% for the week, outperforming the Shanghai Composite Index, which fell 1.30% [6][13] - Year-to-date, the retail index has increased by 6.51%, lagging behind the Shanghai Composite Index's 13.97% rise [13][15] Key Industry Dynamics - The report emphasizes the successful autumn ordering meeting of Chao Hong Ji, showcasing strong demand for new products rooted in traditional craftsmanship and innovative designs [25][26] - The jewelry sector, particularly the high-end and fashion categories, is benefiting from emotional consumption trends, with brands like Lao Pu Gold and Chao Hong Ji recommended for investment [31][39] Company Performance Highlights - Lao Pu Gold reported a revenue of 12.354 billion yuan for H1 2025, a 250.9% increase year-on-year, with a net profit of 2.268 billion yuan, up 285.8% [33][36] - Chao Hong Ji achieved a revenue of 4.102 billion yuan in H1 2025, reflecting a 19.5% increase, with a net profit of 331 million yuan, up 44.3% [39][40] - The report also highlights the performance of other companies such as Mao Ge Ping and Ru Ben, which are experiencing significant growth in the cosmetics sector [32][42] Investment Recommendations - The report suggests focusing on high-quality companies in the emotional consumption theme, particularly in the jewelry and cosmetics sectors, with specific recommendations for Lao Pu Gold, Chao Hong Ji, and Mao Ge Ping [7][31][32]

Market Overview - The personal care products sector increased by 0.82% on September 19, with Beijia leading the gains [1] - The Shanghai Composite Index closed at 3820.09, down 0.3%, while the Shenzhen Component Index closed at 13070.86, down 0.04% [1] Stock Performance - Beijia (603059) closed at 34.19, up 2.46% with a trading volume of 70,200 shares and a turnover of 239 million yuan [1] - Baiya Co. (003006) closed at 28.83, up 2.13% with a trading volume of 29,500 shares and a turnover of 85.02 million yuan [1] - Zhongshun Jierou (002511) closed at 8.52, up 1.79% with a trading volume of 164,400 shares and a turnover of 140 million yuan [1] - Liangmian Needle (600249) closed at 6.19, up 1.14% with a trading volume of 241,200 shares and a turnover of 148 million yuan [1] - Other notable stocks include Dengkang Oral (001328) at 39.11, up 0.51%, and Yiyi Co. (001206) at 28.89, up 0.45% [1] Capital Flow - The personal care products sector experienced a net outflow of 31.20 million yuan from institutional investors, while retail investors saw a net inflow of 22.65 million yuan [2] - The sector's overall capital flow indicates a mixed sentiment among different investor types [2] Individual Stock Capital Flow - Liangmian Needle (600249) had a net inflow of 11.98 million yuan from institutional investors, while retail investors had a net outflow of 16.54 million yuan [3] - Beijia (603059) saw a net inflow of 1.61 million yuan from institutional investors, with retail investors experiencing a net outflow of 7.37 million yuan [3] - Zhongshun Jierou (002511) had a net outflow of 2.91 million yuan from institutional investors, while retail investors had a net inflow of 3.65 million yuan [3]

Group 1 - The core point of the article is that Runben Co., Ltd. announced the election of Xu Huiying as the employee representative director of the company's second board of directors during a recent employee representative meeting [2]

截至本公告披露日，许慧颖女士未持有公司股份，与公司其他董事、高级管理 人员、控股股东、实际控制人、持股 5%以上股东不存在任何关联关系。许慧颖女 士任职资格符合相关法律法规、规范性文件对董事任职资格的要求，不存在《公司 法》《公司章程》等规定不得担任公司董事的情形，也不存在被中国证券监督管理 委员会处以证券市场禁入措施且期限尚未届满的情况，或被证券交易所公开认定为 不适合担任上市公司董事且期限尚未届满的情形，亦不是失信被执行人。公司第二 届董事会中兼任公司高级管理人员以及由职工代表担任的董事人数未超过公司董事 总数的二分之一，符合相关法律法规及公司章程的规定。 特此公告。 证券代码：603193 证券简称：润本股份 公告编号 2025-039 润本生物技术股份有限公司 关于选举产生职工代表董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 润本生物技术股份有限公司（以下简称"公司"）于 2025 年 9 月 3 日召开 2025 年第二次临时股东大会，审议通过《关于取消监事会暨修订<公司章程>的议 案》。本次《公司章程 ...